Retina Health Center offers breakthrough treatment for patients with AMD – SYFOVRE™ (PEGCETACOPLAN INJECTION)
Patients at Retina Health Center are among the first in the nation to have access to SYFOVRE™, a new drug from Apellis Pharmaceuticals, that can slow the progression of retina damage caused by Dry Age-related Macular Degeneration (Dry AMD). Dry AMD is an eye condition in which...